Now available VEGZELMA®

VEGZELMA® (bevacizumab-adcd) is indicated for the treatment of metastatic carcinoma of the colon or rectum, metastatic breast cancer, non-small cell lung cancer, advanced and/or metastatic renal cell cancer, epithelial ovarian/fallopian tube and primary peritoneal cancer, cervical cancer (*based on Vegzelma-SmPC).

Please see full prescribing information here.